Expanding Radiology Possibilities with the Samsung R20: Advanced Imaging Powered by Samsung

SINGAPORE – August 28, 2025 – Scanmed Technology, the official distributor of Samsung Ultrasound Systems in Singapore, is pleased to announce the launch of the Samsung R20, a next-generation ultrasound platform designed to deliver AI-enhanced imaging, quantification, and workflow efficiency for radiologists and general imaging specialists.

The demand for early detection and precise diagnosis continues to grow in Singapore, particularly in areas such as liver disease, breast cancer, and thyroid disorders. Radiologists face the challenge of interpreting a high volume of complex cases while maintaining accuracy and consistency. The Samsung R20 addresses these challenges by integrating state-of-the-art image quality with AI-powered diagnostic tools to support faster, more reliable decision-making.

“The R20 is built to empower radiologists with sharper imaging, automated analysis, and streamlined workflow tools,” said Daniel Soh, Managing Director of Scanmed Technology. “From liver quantification to breast and thyroid lesion analysis, this system brings advanced capabilities that elevate diagnostic confidence while improving efficiency in daily practice.”

Equipped with Samsung’s next-generation imaging engine and GPU technology, the R20 provides radiologists with crystal-clear visualization across patient types, even in difficult scanning conditions. Key imaging features include:

• ShadowHDR™ – enhances visibility of hidden structures by combining high- and low-frequency imaging.

• HQ-Vision™ – reduces blur and sharpens anatomical details.

• MV-Flow™ with LumiFlow™ – captures microvascular and slow blood flow in 3D-like detail.

• ClearVision – noise reduction while preserving edge definition

The R20 also incorporates AI-driven diagnostic support to assist radiologists in daily practice:

• S-Detect™ for Breast & Thyroid – provides automated lesion analysis and standardized reporting (BI-RADS, TI-RADS).

• Live LiverAssist™ with TAI™ & TSI™ – quantifies liver steatosis and scatter for early detection of fatty liver disease.

• S-Shearwave Imaging™ & ElastoScan+™ – measure tissue stiffness for fibrosis and lesion characterization.

• NerveTrack™ – automatically identifies nerve structures during procedures.

By combining AI assistance with quantification tools, the R20 supports radiologists in early detection, treatment planning, and long-term monitoring of patients with confidence.

Workflow efficiency is also central to the R20. With tools such as EzExam+™ customizable protocols, QuickPreset, and EzStructure™ one-touch optimization, radiologists can reduce manual steps and maintain exam consistency across high patient volumes.

“Introducing the R20 in Singapore is part of our ongoing commitment to deliver cutting-edge imaging solutions to healthcare providers,” Soh added. “This system was designed to meet the evolving needs of radiologists, providing precision, efficiency, and versatility in a single platform.”

About Scanmed Technology

Scanmed Technology PTE LTD is a leading medical solutions provider in Singapore, focused on bringing innovative healthcare technologies to the Singapore market. With deep industry experience and a commitment to clinical excellence, Scanmed partners with global innovators to deliver impactful solutions to healthcare professionals.

Find out more:

+65 9093 3196

Solution@scanmed.com.sg